The acquisition will have a $600 million upfront payment and up to another $1.1 billion pending regulatory and commercial milestones, according to an Aug. 20 J&J news release.
V-Wave is a privately held company that targets heart failure with reduced ejection fraction, and its Ventura Interatrial Shunt addressed an unmet need for about 800,000 patients, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
